Back to JACOBS LEVY EQUITY MANAGEMENT, INC JACOBS LEVY EQUITY MANAGEMENT, INC

PTGXPTGX
20 quarters

Position history for JACOBS LEVY EQUITY MANAGEMENT, INCJACOBS LEVY EQUITY MANAGEMENT, INC's holdings in PROTAGONIST THERAPEUTICS INC

JACOBS LEVY EQUITY MANAGEMENT, INC previously held 0 shares of PTGX (PROTAGONIST THERAPEUTICS INC), worth $0 as of 2025-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$191,000

Total Shares Change

-28,400

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q2
Latest
Exited
0
-100.0%
$00.0%$55.69
0
2025-Q1
Unchanged
128,654
0.0%
$6.2M0.0%$48.88
0
2024-Q4
Unchanged
128,654
0.0%
$5M0.0%$38.51
0
2024-Q3
Decreased
128,654
-0.3%
$5.8M0.0%$44.56
0
2024-Q2
Unchanged
129,011
0.0%
$4.5M0.0%$34.65
0
2024-Q1
Unchanged
129,011
0.0%
$3.7M0.0%$28.93
0
2023-Q4
Unchanged
129,011
0.0%
$3M0.0%$22.93
0
2023-Q3
Decreased
129,011
-11.9%
$2.2M0.0%$16.68
0
2023-Q2
Decreased
146,487
-33.7%
$4M0.0%$27.67
0
2023-Q1
Decreased
220,991
-22.2%
$5.1M0.0%$22.49
0
2022-Q4
Increased
284,115
+11.7%
$3.1M0.0%$10.91
29
2022-Q3
New
254,340
-
$2.1M0.0%$8.25
36
2020-Q3
Exited
0
-100.0%
$00.0%$20.25
0
2020-Q2
Decreased
68,279
-5.6%
$1.2M0.0%$17.39
0
2020-Q1
Decreased
72,357
-21.2%
$511,0000.0%$7.17
0
2019-Q4
Increased
91,831
+565.0%
$647,0000.0%$7.16
39
2019-Q3
New
13,810
-
$166,0000.0%$13.15
31
2019-Q2
Exited
0
-100.0%
$00.0%$12.11
0
2019-Q1
Decreased
21,700
-23.6%
$273,0000.0%$12.57
0
2018-Q4
New
28,400
-
$191,0000.0%$6.36
31

Other major holders of PTGX: BlackRock, Inc., FARALLON CAPITAL MANAGEMENT, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used